Nurix Therapeutics (NRIX) Other Gross PP&E Adjustments (2019 - 2025)
Historic Other Gross PP&E Adjustments for Nurix Therapeutics (NRIX) over the last 7 years, with Q4 2025 value amounting to $439000.0.
- Nurix Therapeutics' Other Gross PP&E Adjustments fell 9766.61% to $439000.0 in Q4 2025 from the same period last year, while for Nov 2025 it was $439000.0, marking a year-over-year decrease of 9766.61%. This contributed to the annual value of $439000.0 for FY2025, which is 9766.61% down from last year.
- Latest data reveals that Nurix Therapeutics reported Other Gross PP&E Adjustments of $439000.0 as of Q4 2025, which was down 9766.61% from $5.7 million recorded in Q3 2025.
- Over the past 5 years, Nurix Therapeutics' Other Gross PP&E Adjustments peaked at $49.7 million during Q2 2025, and registered a low of $439000.0 during Q4 2025.
- Over the past 5 years, Nurix Therapeutics' median Other Gross PP&E Adjustments value was $19.6 million (recorded in 2021), while the average stood at $19.5 million.
- In the last 5 years, Nurix Therapeutics' Other Gross PP&E Adjustments surged by 19194.47% in 2024 and then crashed by 9766.61% in 2025.
- Quarter analysis of 5 years shows Nurix Therapeutics' Other Gross PP&E Adjustments stood at $11.2 million in 2021, then surged by 84.96% to $20.6 million in 2022, then tumbled by 68.79% to $6.4 million in 2023, then soared by 191.94% to $18.8 million in 2024, then crashed by 97.67% to $439000.0 in 2025.
- Its Other Gross PP&E Adjustments was $439000.0 in Q4 2025, compared to $5.7 million in Q3 2025 and $49.7 million in Q2 2025.